MedWatch

Top picks in English

Varct receives funds for cancer research – in talks with potential partners

Varct Diagnostics, which is developing a method to detect cancer from a single blood sample, has received DKK 15 million from the Innovation Fund Denmark, to be spent on fully developing the method and validating it for humans next year. The goal is to license the technology to a major international diagnostics firm, and talks are ongoing, says CEO.

EMA nominates its new Executive Director

During an extraordinary meeting Thursday, the European Medicines Agency, EMA, nominated Irish Emer Cooke to head the agency once the current executive director steps down on Nov. 1 after ten years in office.

This is how EMA chooses its new executive director

Thursday, two candidates face their perhaps most important exam to date, when they have to convince the European Medicines Agency that they should be the agency's new executive director. DMA's director general, Thomas Senderovitz, sits on the board of the EMA and he provides and insight into the process before, during and after.

Overview: Here are the allegations against the SSI directors

Kammeradvokaten, legal counsel to the Danish government, accuses CEO of Danish organization Statens Serum Institut, Mads Melbye, and EVP of research Peter Lawætz Andersen of "gross breach of the rules about disqualification" as well as several other issues.

Janssen to change Danish setup: We are changing the regional focus

Julie Enevold Brooker is Janssen's first country director in Denmark for decades, and has been hired to transform the pharmaceutical giant's nordic and regional focus, instead making the company an expert on the Danish healthcare system before the company launches a number of crucial new products.